Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 933 clinical trials
Featured trial
Episodic Migraine: Phase 3 Study of BOTOX (Botulinum Toxin Type A) for the Prevention of Migraine in Subjects with Episodic Migraine

The purpose of this study is to see if the study drug, BOTOX®, is safe and helps prevent episodic migraines in adults that experience 6-14 migraine days per month and less than 15 headache days per month. This study is for research purposes only. This study will help the sponsor, …

  • 1 views
  • 21 Apr, 2022
  • 1 location
Featured trial
Participate In Research To Help Women With A History Of Physical Or Sexual Assault/Abuse

Participate In Research To Help Women With A History Of Physical Or Sexual Assault/Abuse

  • 624 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Novel Multimodal Assessment of Practical Judgment Across the Alzheimer's Continuum: Toward a Better Understanding of how to Predict Risk in the Elderly

detection of diminished capacity as a means to improve personal safety and prevent financial exploitation and abuse. The purpose of this study is to determine how early, mild changes in practical judgment and

alzheimer's disease
Accepts healthy volunteers
  • 0 views
  • 25 Jul, 2022
  • 1 location
Featured trial
Characterizing Risk Factors for Burden in Caregivers to Individuals with Alzheimer’s Disease and Frontotemporal Dementia

>neurological or psychiatric disease (e.g., stroke), history of drug abuse, vision, hearing,cognitive, or motor difficulties, or if you are currently pregnant. For more

mild cognitive impairment
Accepts healthy volunteers
stroke
cognitive impairment
dementia
  • 9 views
  • 19 Aug, 2022
  • 1 location
Featured trial
TAKEDA EXAMINE trial patients for who have Type II diabetes & ACS coronary artery disease, post angiogram or heart attack. This is a phase 3b study. Currently open for enrollment.

TAKEDA EXAMINE trial patients for who have Type II diabetes & ACS coronary artery disease, post angiogram or heart attack. This is a phase 3b study. Currently open for enrollment.

  • 303 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Double blind, randomized, historical control study of the safety and efficacy of Eslicarbazepine Acetate Monotherapy in subjects with partial epilepsy not well controlled by current antiepileptic drugs

Double blind, randomized, historical control study of the safety and efficacy of Eslicarbazepine Acetate Monotherapy in subjects with partial epilepsy not well controlled by current antiepileptic drugs

  • 736 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Multicenter Study Of Study Medicine On Peripheral Nerve Function In Patients With Osteoarthritis

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Multicenter Study Of Study Medicine On Peripheral Nerve Function In Patients With Osteoarthritis

  • 483 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A Randomized, Double-Blinded, Placebo-Controlled Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB037 in Subjects With Prodromal or Mild Alzheimer's Disease

A Randomized, Double-Blinded, Placebo-Controlled Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB037 in Subjects With Prodromal or Mild Alzheimer's Disease

  • 87 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Bipolar Depression study with 6-month open-label therapy

Bipolar Depression study with 6-month open-label therapy

  • 3575 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A Phase Ii, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of Ro4602522 Added To The Background Therapy Of The Acetylcholinesterase Inhibitors Donepezil Or Rivastigmine In Patients With Moderate Severity Alzheimer's Disease

A Phase Ii, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of Ro4602522 Added To The Background Therapy Of The Acetylcholinesterase Inhibitors Donepezil Or Rivastigmine In Patients With Moderate Severity Alzheimer's Disease

  • 174 views
  • 25 Mar, 2021
  • 1 location